Pasithea Therapeutics Corp.

Developing innovative therapeutics for CNS disorders (ALS, MS) and RASopathies.

KTTA | US

Overview

Corporate Details

ISIN(s):: US70261F1030
LEI:
Country:: United States of America
Address:: 1111 LINCOLN ROAD, SUITE 500, 33139 MIAMI BEACH
Website:: https://www.pasithea.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Pasithea Therapeutics Corp. is a clinical-stage biotechnology company focused on the discovery, research, and development of innovative treatments for central nervous system (CNS) disorders and RASopathies. The company is dedicated to creating new therapeutics for complex neurological and psychiatric conditions with significant unmet medical needs. Its primary research pipeline targets treatments for Neurofibromatosis type 1 (NF1), Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and schizophrenia.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
	2025-11-04 13:04	Regulatory News Service 8-K - Pasithea Therapeutics Corp. (0001841330) (Filer)	English	145.9 KB

Automate Your Workflow. Get a real-time feed of all Pasithea Therapeutics Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pasithea Therapeutics Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Pasithea Therapeutics Corp. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
HISAMITSU PHARMACEUTICAL CO.,INC. A global leader in transdermal drug delivery systems for OTC and prescription pain relief.	Japan	4530
HLB Genex, Inc. Develops custom enzymes & microbiome solutions for diagnostics, nutrition, and cosmetic markets.	South Korea	187420
HLB INC. A diversified group in pharma, shipbuilding, life sciences, and professional advisory services.	South Korea	028300
HLB Life Science CO.,LTD. Develops anti-cancer drugs and distributes IVD medical devices and lab supplies internationally.	South Korea	067630
HLB PANAGENE Co., LTD. A global leader in PNA technology for cancer diagnostics and precision medicine.	South Korea	046210
HLB Pep Co., Ltd. Develops and produces GMP peptides, APIs, and custom synthesis for the biopharma industry.	South Korea	196300
HLB PHARMACEUTICAL CO., LTD. Researches cancer drugs and offers pharmaceutical CMO and manufacturing services.	South Korea	047920
HLB SCIENCE Inc. Develops innovative therapeutics and diagnostics for infectious and neurodegenerative diseases.	South Korea	343090
H. Lundbeck A Develops and commercializes innovative therapeutics for brain diseases globally.	Denmark	HLUN
Hoth Therapeutics, Inc. Advancing therapeutics for metabolic, dermatologic, and inflammatory diseases.	United States of America	HOTH